CN1235635C - Medicine for treating osteosis - Google Patents
Medicine for treating osteosis Download PDFInfo
- Publication number
- CN1235635C CN1235635C CNB031442234A CN03144223A CN1235635C CN 1235635 C CN1235635 C CN 1235635C CN B031442234 A CNB031442234 A CN B031442234A CN 03144223 A CN03144223 A CN 03144223A CN 1235635 C CN1235635 C CN 1235635C
- Authority
- CN
- China
- Prior art keywords
- medicine
- root
- present
- blood
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses medicine for treating hyperosteogeny, which is prepared from the following raw material by weight proportions: 50g of tortoise plastron, 50g of turtle shell, 15g of pangolin scales, 30g of red sage root, 15g of safflower, 15g of peach kernel, 20g of common prism rhizome, 20g of zedoary, 20g of frankincense, 20g of myrrh, 15g of twotooth achyranthes root and 10g of liquoric root. The medicine has the functions of body resistance strengthening, evil elimination and treatment of both the manifestation and the root cause of a disease, wherein pangolin scales is used as a medicinal usher, and other medicine is introduced to focuses; tortoise plastron and turtle shell have the function of body resistance strengthening so that hyperplastic bones are softened gradually and disappear, and other medicine has the integrated functions of blood nourishing, blood circulation activation, blood stasis dissipation, menstrual flow restoration, swelling elimination, pain alleviation, detoxification, etc. Clinical practice shows that the medicine has an effective rate of 100% and a cure rate of 100%. Moreover, the present invention has the advantages of short treatment time, low cost and obvious effect, patients can be cured after 6 doses of the medicine are taken, and the present invention is ideal medicine for treating hyperostosis.
Description
Technical field: the invention belongs to technical field of Chinese medicines, relate to a kind of medicine for the treatment of hyperosteogeny specifically.
Background technology: hyperosteogeny is a kind of commonly encountered diseases, frequently-occurring disease, and its sickness rate is the trend that increases year by year.Low and the relapse rate height of this disease cure rate, the patient who has through several years, more than ten years in addition treatment decades still can not fully recover, to such an extent as to influence normal live and work, and cause heavy financial burden and mental burden.At present, the medicine that many treatment hyperosteogenys are arranged clinically, the external that also has for oral administration is arranged, but all exist such or such problem, Os Elephatis have the subsides medicine of the liniment of a clever class and bony-spur plaster one class and bony spur tablet one class Chinese patent medicine for oral administration etc. then ubiquity drug effect low, the medicine that take effect slow problem, wherein has also has certain side effect, for a long time with easily producing dependency and Drug resistance.
Summary of the invention:
Task of the present invention is at the deficiencies in the prior art, by excavating motherland's medical treasure-house, to provide a kind of medicine for the treatment of hyperosteogeny.
Technical solution of the present invention is:
A kind of medicine for the treatment of hyperosteogeny is characterized in that its constituent content is as follows:
Carapax et Plastrum Testudinis 50g Carapax Trionycis 50g Squama Manis 15g Radix Salviae Miltiorrhizae 30g Flos Carthami 15g Semen Persicae 15g
Rhizoma sparganic 20g Rhizoma Curcumae 20g Olibanum 20g Myrrha 20g Radix Achyranthis Bidentatae 15g Radix Glycyrrhizae 10g.
Said components side separates: wherein Carapax et Plastrum Testudinis salty, sweet, be slightly cold, return Liver and kidney, heart channel, its effect is nourishing YIN for suppressing the hyperactive YANG, kidney tonifying bone strengthening, the reinforcing the heart of nourishing blood; Carapax Trionycis is salty, be slightly cold, and returns liver, kidney channel, and its effect is nourishing YIN for suppressing the hyperactive YANG, hard masses softening and resolving; Carapax et Plastrum Testudinis and Carapax Trionycis are in this mutual reinforcement between and usefulness, and the former is partial to YIN nourishing, replenishing kidney and strengthening bone, and the latter is longer than softening the hard mass, heat clearing away and gets through blood vessels, and the two is a monarch drug, brings out the best in each other.Squama Manis wherein is salty, be slightly cold, and returns liver, stomach warp, and its function mainly is to live and learns blood stasis dispelling, and can guide meridians, is ministerial drug.All the other are adjuvant, wherein Radix Salviae Miltiorrhizae has the effect that nourshing blood and promoting blood circulation, relieving restlessness are calmed the nerves, the merit that Flos Carthami has blood circulation promoting and blood stasis dispelling, stimulates the menstrual flow, rhizoma sparganic, two of Rhizoma Curcumae have removing mass blood, change the merit of congestion, the Semen Persicae silt of stimulating the menstrual flow brokenly, Olibanum, Myrrha circulation of qi promoting, invigorate blood circulation, pain relieving, broken loosing become silted up, Radix Achyranthis Bidentatae is broken loose become silted up, promoting the circulation of QI to relieve pain, Radix Glycyrrhizae has the effect of coordinating the actions of various ingredients in a prescription, separates the poison of all medicines.The mechanism of action of this medicine is to set upright to remove heresy, treating both the principal and secondary aspects of a disease.Wherein Squama Manis is led the way, and follows through all guiding drugs are gone into focus; Carapax et Plastrum Testudinis, Carapax Trionycis are set upright, and outgrowth sclerotin is softened bit by bit and makes it further disappearance; The comprehensive performance of other medicines is nourished blood, is invigorated blood circulation, blood stasis dispelling, stimulate the menstrual flow, effects such as detumescence, pain relieving, detoxifcation.
Adopt this prescription, the inventor had once successfully thoroughly cured hundreds of routine patients, and it is as follows now to lift two model cases:
Case 1, Fu Guiqin, the woman, 48 years old, Xinglong County Liu Daohe town Liu Daohe village peasant, on June 15th, 2003 examined.Medical history information summary: Xinglong County hospital CT examination report: L
5Vertebral body is the slippage of I degree forward, L
4/ 5 annuler bulge.The master states the seat time and has grown pain unbearably.With six doses of recoveries from illness of this medicine, be seated existing all day and do the sewing machine work and have no pain.
Case history 2, Lin Shouhe, the man, 64 years old, Xinglong County Dadong District people, on April 11st, 2002 came to go to a doctor, and the master states lumbago, and moving difficulty is diagnosed as prolapse of lumbar intervertebral disc in the county hospital screening.With six doses of recoveries from illness of this medicine.
Compared with prior art, the present invention writes out a prescription and adopts traditional Chinese herbal medicine, and its component structure is reasonable, and compatibility is rigorous, and clinical practice proves: this medicine treatment hyperosteogeny effective percentage 100%, cure rate 100%.And treatment time is short, and expense is low, can be described as a kind of ideal medicament for the treatment of hyperosteogeny.At present, this medicine can suitability for industrialized production, and large-area applications is in clinical.
The specific embodiment: the present invention is elaborated below in conjunction with embodiment.
Embodiment, it is some to get raw medicinal material by the component ratio of Carapax et Plastrum Testudinis 50g Carapax Trionycis 50g Squama Manis 15g Radix Salviae Miltiorrhizae 30g Flos Carthami 15g Semen Persicae 15g rhizoma sparganic 20g Rhizoma Curcumae 20g Olibanum 20g Myrrha 20g Radix Achyranthis Bidentatae 15g Radix Glycyrrhizae 10g, with wherein Carapax et Plastrum Testudinis, Carapax Trionycis and three kinds of medicines of Squama Manis are directly clayed into power, and with other medicine through boiling-purify-process such as concentrate makes medicated powder, then, again with behind two kinds of medicated powder mix homogeneously, or directly incapsulate, or adopt the routine techniques of Chinese medicine west system to be processed into tablet.
Claims (1)
1, a kind of medicine for the treatment of hyperosteogeny is characterized in that it is made by following raw material:
Carapax et Plastrum Testudinis 50g Carapax Trionycis 50g Squama Manis 15g Radix Salviae Miltiorrhizae 30g Flos Carthami 15g Semen Persicae 15g
Rhizoma sparganic 20g Rhizoma Curcumae 20g Olibanum 20g Myrrha 20g Radix Achyranthis Bidentatae 15g Radix Glycyrrhizae 10g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031442234A CN1235635C (en) | 2003-08-29 | 2003-08-29 | Medicine for treating osteosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031442234A CN1235635C (en) | 2003-08-29 | 2003-08-29 | Medicine for treating osteosis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1493344A CN1493344A (en) | 2004-05-05 |
CN1235635C true CN1235635C (en) | 2006-01-11 |
Family
ID=34240427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031442234A Expired - Fee Related CN1235635C (en) | 2003-08-29 | 2003-08-29 | Medicine for treating osteosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1235635C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940847A (en) * | 2015-07-23 | 2015-09-30 | 朱阁林 | Formula of traditional Chinese medicine for treating lumbar vertebrae hyperosteogeny |
-
2003
- 2003-08-29 CN CNB031442234A patent/CN1235635C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1493344A (en) | 2004-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100488549C (en) | Externally applied medicament for treating rheumatism | |
CN1095610A (en) | The pharmaceutical preparation Fubingkang of treatment, prevention gynecological diseases | |
CN101485836A (en) | Oral capsule for treating neck, waist and leg pain diseases and preparation method thereof | |
CN1803187A (en) | Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny | |
CN102940853B (en) | Navel paste for treating mammary gland hyperplasia diseases | |
CN101507783A (en) | Medicinal wine capable of treating | |
CN1150925C (en) | Chinese Patent medicine for curing deafness | |
CN1117582C (en) | medicine for treating rheumatoid arthritis and preparing process thereof | |
CN1135909A (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
CN100381155C (en) | Medicine for treating mammary glands hyperplasia | |
CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
CN102641471B (en) | Traditional Chinese medicine for treating cholelithiasis | |
CN1234385C (en) | Health-care medicinal plaster used for preventing and curing discopathy, osteosis, ischialgia | |
CN101411799B (en) | Oral medicinal liquor for treating rheumatism and rheumatoid disease | |
CN1235635C (en) | Medicine for treating osteosis | |
CN100546597C (en) | A kind of Chinese medicine for the treatment of hyperosteogeny, rheumatic and rheumatoid arthritis and sciatica | |
CN105770294A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
CN1136899C (en) | Chinese medicine for treating mastoplasia | |
CN102836346B (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
CN202478145U (en) | Gynaecological tumor acupoint therapy apparatus | |
CN1101693C (en) | Externally applied Chinese medicine | |
CN1994415B (en) | Orally administered Chinese medicine for treating dysmenorrhea | |
CN1130220C (en) | Chinese medicine 'Shexianfengshi wan' | |
CN1076622C (en) | Chinese medicine for curing nephritis | |
CN100353995C (en) | Pharmaceutical composition with functions of dispersing pathogenic wind, activating collaterals ,and clearing away toxin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060111 Termination date: 20090929 |